Aether Holdings, Inc..
ATHR.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Aether Holdings, Inc., through its subsidiaries, operates as a specialty pharmaceutical company. It focuses on the acquisition, development, and commercialization of products to treat unmet medical needs in critical care settings. The company's primary product is Vasopressin, an injection indicated ...Show More
Better Health for All
0
Aether Holdings has a privacy policy that details its data collection practices, including security precautions, user opt-out options, third-party data sharing, data transfer policies, and user rights regarding their data.
1
No other sustainability data or information regarding the company's health impact, safety record, pricing, or other health-related initiatives is publicly available.
2
Fair Money & Economic Opportunity
0
No evidence available to assess Aether Holdings, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
20
The company has an average Glassdoor rating of 4.47 out of 5, based on 14 employee reviews, indicating a high level of employee satisfaction.
1
This rating translates to approximately 89.4% satisfaction. Specific category ratings include Culture & values at 4.0/5, Diversity, Equity & Inclusion at 4.6/5, Work/Life balance at 3.9/5, Senior management at 3.4/5, and Compensation and benefits at 3.6/5.
2
Fair Trade & Ethical Sourcing
0
No information was found in the provided articles regarding Aether Holdings, Inc.'s fair trade and ethical sourcing practices.
1
Specifically, there is no evidence concerning fair-trade certification share, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend.
2
Honest & Fair Business
0
Aether Holdings, Inc. replaced its auditor, ZH CPA, LLC, with KNAV CPA LLP effective January 22, 2026.
1
The prior auditor issued no adverse opinions, qualifications, or modifications regarding accounting principles for the fiscal years ended September 30, 2025, and September 30, 2024.
2
However, ZH CPA, LLC had a 100% failure rate in PCAOB audits reviewed in 2023, and its report for fiscal year 2024 included an explanatory paragraph raising substantial doubt about Aether’s ability to continue as a going concern.
3
The company's board of directors initiated an internal investigation into potential undisclosed affiliations of the CEO and Chairman, Nicolas Lin, with a shareholder.
4
SEC filings contained material misrepresentations regarding the relationship between ATHR and 28 Ventures, and failed to disclose CEO Nicolas Lin's role as CFO of Origin Investment Corp I (ORIQ) and Frank Cid's permanent bar by FINRA.
5
The company also filed its quarterly results late on May 16, 2025, and a notice of inability to timely file its 10-Q on August 14, 2025.
6
The company states compliance with anti-corruption laws like the U.S. FCPA and U.K. Bribery Act, and relies on liquidity providers to implement controls to mitigate sanction risks.
7
Operational procedures of custodians are periodically reviewed by third-party advisors, and the company intends to obtain and review custodians' services organization controls reports and periodically verify bitcoin holdings.
8
Kind to Animals
0
No specific evidence was found in the provided articles pertaining to ATHR.US (Aether Holdings, Inc.), a specialty pharmaceutical company. Articles
1
and
2
refer to 'ATHR Beauty,' a beauty brand, which is not explicitly stated to be a subsidiary or product line of ATHR.US.
3
The remaining articles
4
,
5
,
6
,
7
discuss general industry trends, regulations, and funding for non-animal testing methods but do not mention ATHR.US directly. Therefore, no KPIs can be scored for ATHR.US based on the provided information.
No War, No Weapons
0
The provided articles do not contain any specific, concrete data points regarding Aether Holdings, Inc. (ATHR.US), the specialty pharmaceutical company, in relation to the 'No War, No Weapons' ethical value. Several articles refer to a 'financial technology company' also named Aether Holdings Inc., which is distinct from the pharmaceutical company described in the prompt.
1
Other articles are general IPO overviews, discussions of a corporate finance professional's experience, or broad analyses of the US defense industry, none of which mention ATHR.US (the pharmaceutical company) or its activities relevant to the specified KPIs.
Planet-Friendly Business
0
No specific, concrete data points for Aether Holdings, Inc. (ATHR.US), a specialty pharmaceutical company, were found in the provided articles. The articles refer to 'Aether Fuels' (focused on sustainable aviation fuel) and 'Aether Industries Limited' (focused on chemicals and manufacturing). The evidence does not explicitly state that these entities are subsidiaries of Aether Holdings, Inc. (ATHR.US) or that their environmental performance data applies to the pharmaceutical operations of ATHR.US. Therefore, no KPIs could be scored based on the provided information and strict evidence rules.
Respect for Cultures & Communities
0
No specific, concrete evidence was found across the provided articles to assess Aether Holdings, Inc. against any of the KPIs for the 'Respect for Cultures & Communities' ethical value. The articles primarily focus on corporate financial announcements, subsidiary launches, and executive appointments, without providing data on community engagement, cultural impact, local employment, grievance mechanisms, or related metrics. The single partnership mentioned is a business collaboration, not with indigenous or local community groups.
1
Safe & Smart Tech
0
No evidence available to assess Aether Holdings, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
-50
The company has maintained a record of no waste disposal violations in the past three years (FY 2019-20 to FY 2021-22).
1
It implements hazardous waste management systems and has shown a reduction in used/spent oil, from 0.69372 MT in FY 2020-21 to 0.21648 MT in FY 2021-22.
2
Aether has several waste reduction initiatives, including streamlining production, optimizing raw material use, segregating recyclable materials, operating a Solvent Recovery Plant, and utilizing a 100 KLPD Zero Liquid Discharge plant.
3
The company integrates a 4R strategy (reduce, recover, recycle, reuse) into its engineering designs and employs green chemistry principles.
4
It has partnered with Novoloop to transform post-consumer plastic waste into monomers and commercialized sustainable Converge polyols technology.
5
The company has quantitative waste reduction targets, expecting plastic intake capacity to reach 70 metric tons/year by the end of 2024 through its partnership with Novoloop.
6
Suppliers are expected to comply with Aether's environmental and social responsibility policies.
7
The company optimizes raw material use and employs cleaner chemistries for material efficiency.
8
However, no facilities have zero waste certification.
9